Shanshan Ding’s group [25] analyzed EGFR activating mutations, as well as the T790M resistance mutation, in paired saliva and plasma ctDNA of 27 NSCLC patient’s cohort. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.